Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

Nature Genetics

Volumn 35, Issue 1, 2003, Pages 76-83

  Zuccato, Chiara ^a   Tartari, Marzia ^a   Crotti, Andrea ^a   Goffredo, Donato ^a   Valenza, Marta ^a   Conti, Luciano ^a   Cataudella, Tiziana ^a   Leavitt, Blair R ^b   Hayden, Michael R ^b   Timmusk, Tõnis ^c,d   Rigamonti, Dorotea ^a   Cattaneo, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HUNTINGTIN; NEURON RESTRICTIVE SILENCER ELEMENT; REPRESSOR ELEMENT 1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN FUNCTION; GENE INSERTION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUNTINGTON CHOREA; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; SILENCER GENE; TRANSCRIPTION REGULATION; TRINUCLEOTIDE REPEAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; HUNTINGTON DISEASE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; SILENCER ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; INSERTION SEQUENCES;

EID: 0041353535     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1219     Document Type: Article

References (30)

1. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 72, 971-983 (1993).
2. Zuccato, C. et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498 (2001).
3. Chong, J.A. et al. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80, 949-957 (1995).
4. Schoenherr, C.J. & Anderson, D.J. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267, 1360-1363 (1995).
5. Schoenherr, C.J., Paquette, A.J & Anderson, D.J. Identification of potential target genes for the neuron-restrictive silencer factor. Proc. Natl. Acad. Sci. USA 93, 9881-9886 (1996).
6. Rubinsztein, D.C. Lessons from animal models of Huntington's disease. Trends Genet. 18, 202-209 (2002).
7. Cattaneo, E. et al. Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci. 24, 182-188 (2001).
8. Timmusk, T. et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475-489 (1993).
9. Timmusk, T. et al. Identification of brain-derived neurotrophic factor promoter regions mediating tissue-specific, axotomy-, and neuronal activity-induced expression in transgenic mice. J. Cell Biol. 128, 185-199 (1995).
10. Ehrlich, M.E. et al. ST14A cells have properties of a medium-spiny neuron. Exp. Neurol. 167, 215-226 (2001).
11. Rigamonti, D. et al. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. 20, 3705-3713 (2000).
12. Trettel, F. et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9, 2799-2809 (2000).
13. Nasir, J. et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823 (1995).
14. Timmusk, T., Palm, K., Lendahl, U. & Metsis, M. brain-derived neurotrophic Factor expression in vivo is under the control of neuron-restrictive silencer element. J. Biol. Chem. 274, 1078-1084 (1999).
15. Huang, Y., Myers, S.J. & Dingledine, R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat. Neurosci. 2, 867-872 (1999).
16. Ballas, N. et al. Regulation of neuronal traits by a novel transcriptional complex. Neuron 31, 353-365 (2001).
17. Palm, K., Belluardo, N., Metsis, M. & Timmusk, T. Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene. J. Neurosci. 18, 1280-1296 (1998).
18. Palm, K., Metsis, M. & Timmusk, T. Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat. Brain Res. Mol. Brain Res. 72, 30-39 (1999).
19. Koenigsberger, C., Chicca, J.J.2nd, Amoureux, M.C., Edelman, G.M. & Jones, F.S. Differential regulation by multiple promoters of the gene encoding the neuron-restrictive silencer factor Proc. Natl. Acad. Sci. USA 97, 2291-2296 (2000).
20. Lee, J.H., Shimojo, M., Chai, Y.G. & Hersh, L.B. Studies on the interaction of REST4 with the cholinergic repressor element-1/neuron restrictive silencer element. Brain Res. Mol. Brain Res. 80, 88-98 (2000).
21. Shimojo, M., Lee, J.H. & Hersh, L.B. Role of zinc finger domains of the transcription factor neuron-restrictive silencer factor/repressor element-1 silencing transcription factor in DNA binding and nuclear localization. J. Biol. Chem. 276, 13121-13126 (2001).
22. Hodgson, J.G. et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neurol 23, 181-192 (1999).
23. Dyer, R.B. & McMurray, C.T. Mutant protein in Huntington's disease is resistant to proteolysis in affected brain. Nat. Genet. 29, 270-278 (2001).
24. Wellington, C.L. et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158-9167 (1998).
25. Kim, Y.J. et al. Caspase 3 cleavage N-terminal fragment of wild-type or mutant huntingtin are presented in normal and Huntington's disease brain associate with membrains and undergo calpain dependent proteolysis. Proc. Natl. Acad. Sci. USA 98, 12784-12789 (2001).
26. Gafni, J & Ellerby, L.M. Calpain activation in Huntington's disease. J. Neurosci. 22, 4842-4849 (2002).
27. Zhang, Y et al. Depletion of wild-type Huntingtin in mouse models of neurologic diseases. J. Neurochem. (in the press).
28. Steffan, J.S. et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739-743 (2001).
29. Goffredo, D. et al. Calcium-dependent cleavage of endogenous wild-type Huntingtin in primary cortical neurons. J. Biol. Chem. 277, 39594-39598 (2002).
30. Gorski, K., Carneiro, M. & Schibler, U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47, 767-776 (1986).